Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.76 USD | +0.59% |
|
+6.03% | +18.71% |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.71% | 1.51B | |
+56.67% | 815B | |
+43.90% | 641B | |
-6.79% | 352B | |
+17.49% | 314B | |
+9.45% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+8.04% | 168B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Transcript : Ligand Pharmaceuticals Incorporated, Q3 2022 Earnings Call, Nov 07, 2022